Status:
UNKNOWN
CE-MRI&CESM in Solid Breast Lesions
Lead Sponsor:
Assiut University
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18-75 years
Brief Summary
Our study aimed to assess the accuracy of CE-SM in comparison to contrast-enhanced breast MRI in the evaluation of solid breast lesions.
Detailed Description
Breast cancer is the most common cancer in women, responsible for 23% of cancer in females worldwide (1). Early detection and accurate diagnosis of breast cancer aims to reduce morbidity and mortalit...
Eligibility Criteria
Inclusion
- Patients who have previously undergone mammography (MG) and ultrasound and have a solid (BIRADs III and more) breast lesion.
Exclusion
- Cystic breast lesions
- BIRADs I and II breast lesions(benign)
- Pregnancy
- History of allergic reaction to iodinated contrast agent
- Renal insufficiency
- Other contraindications to MRI include pacemaker, claustrophobia or metal prosthesis.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04832191
Start Date
April 1 2021
End Date
May 1 2023
Last Update
April 5 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.